AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Pilgrim's Pride today, you need to believe that a relatively low valuation and strong brands can outweigh near term earnings pressure and a cyclical protein market. The recent estimate cuts reinforce that profit is under strain, but they do not materially change the key short term catalyst, which is how upcoming results confirm or challenge the profit reset, or the main risk, which is prolonged margin compression in a high cost, competitive industry.
Among recent announcements, the Q1 2026 results are most relevant to the latest earnings downgrades. Sales were broadly flat year over year at US$4,532.63 million, but net income fell sharply to US$101.42 million from US$296.03 million, underscoring how fast profitability can contract even when revenue holds up. That pattern sits at the heart of today’s catalyst and risk debate, because it shows how sensitive Pilgrim’s Pride remains to shifts in costs and pricing.
Yet while some may focus only on valuation, investors should also be aware of the risk that sustained margin pressure could...
Read the full narrative on Pilgrim's Pride (it's free!)
Pilgrim's Pride's narrative projects $19.3 billion revenue and $826.3 million earnings by 2029.
Uncover how Pilgrim's Pride's forecasts yield a $37.62 fair value, a 29% upside to its current price.
Before this downgrade, the most bearish analysts were already assuming roughly flat revenue near US$18.8 billion and earnings of about US$678.0 million, so their more pessimistic view of weaker margins and slower benefit from new prepared foods capacity may now look closer to current risks than the consensus, reminding you that reasonable investors can read the same numbers very differently and that both narratives may need updating as the new profit outlook sinks in.
Explore 3 other fair value estimates on Pilgrim's Pride - why the stock might be worth over 3x more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com